Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 12.11.2018 1 Am J Surg 8 Anticancer Res 3 BMC Cancer 1 Br J Cancer 3 Cancer Lett 1 Cancer Res 2 Dis Colon Rectum 2 Eur J Surg Oncol 14 Gastrointest Endosc 2 Gut 4 Int J Cancer 3 Int J Colorectal Dis 5 J Surg Oncol 1 N Engl J Med 1 Oncogene 1 Oncol Rep 1 Oncology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. DURAES LC, Steele SR, Camargo MGM, Gorgun E, et al
   Conversion to open from laparoscopic colon resection is a marker for worse oncologic outcomes in colon cancer.
   Am J Surg. 2018 Oct 31. pii: S0002-9610(18)30969.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. WANG B, Ogata H, Takishima Y, Miyamoto S, et al
   A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
   Anticancer Res. 2018;38:6121-6126.
   PubMed     Text format     Abstract available
   
   
3. NAKURTE I, Jekabsons K, Rembergs R, Zandberga E, et al
   Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
   Anticancer Res. 2018;38:6133-6138.
   PubMed     Text format     Abstract available
   
   
4. SEMAAN C, Neilson KA, Brown B, Molloy MP, et al
   Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.
   Anticancer Res. 2018;38:6195-6200.
   PubMed     Text format     Abstract available
   
   
5. SUEHIRO Y, Takemoto Y, Nishimoto A, Ueno K, et al
   Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
   Anticancer Res. 2018;38:6225-6230.
   PubMed     Text format     Abstract available
   
   
6. DA SILVA MACHADO F, Munari FM, Scariot FJ, Echeverrigaray S, et al
   Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status.
   Anticancer Res. 2018;38:6231-6236.
   PubMed     Text format     Abstract available
   
   
7. ENKHBAT T, Nishi M, Yoshikawa K, Jun H, et al
   Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy.
   Anticancer Res. 2018;38:6247-6252.
   PubMed     Text format     Abstract available
   
   
8. MASUDA T, Margonis GA, Andreatos N, Wang J, et al
   Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
   Anticancer Res. 2018;38:6353-6360.
   PubMed     Text format     Abstract available
   
   
9. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
   Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.
   Anticancer Res. 2018;38:6399-6404.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. MAHMOOD S, English DR, MacInnis RJ, Karahalios A, et al
    Domain-specific physical activity and the risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study.
    BMC Cancer. 2018;18:1063.
    PubMed     Text format     Abstract available
    
    
11. TIAN Y, Li J, Zhou T, Tong D, et al
    Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
    BMC Cancer. 2018;18:1084.
    PubMed     Text format     Abstract available
    
    
12. LUALDI M, Cavalleri A, Battaglia L, Colombo A, et al
    Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors.
    BMC Cancer. 2018;18:841.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

13. MA Y, Yang W, Song M, Smith-Warner SA, et al
    Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts.
    Br J Cancer. 2018 Nov 7. pii: 10.1038/s41416-018-0314.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

14. ZHANG YK, Wang YJ, Lei ZN, Zhang GN, et al
    Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
    Cancer Lett. 2018 Oct 27. pii: S0304-3835(18)30647.
    PubMed     Text format     Abstract available
    
    
15. DENG Q, Geng Y, Zhao L, Li R, et al
    NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.
    Cancer Lett. 2018;442:21-30.
    PubMed     Text format     Abstract available
    
    
16. JIN F, Yang R, Wei Y, Wang D, et al
    HIF-1alpha-induced miR-23a approximately 27a approximately 24 cluster promotes colorectal cancer progression via reprogramming metabolism.
    Cancer Lett. 2019;440-441:211-222.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

17. LAN J, Sun L, Xu F, Liu L, et al
    M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer.
    Cancer Res. 2018 Nov 6. pii: 0008-5472.CAN-18-0014.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

18. CHOUHAN H, Ferrandon S, DeVecchio J, Kalady MF, et al
    A Changing Spectrum of Colorectal Cancer Biology With Age: Implications for the Young Patient.
    Dis Colon Rectum. 2018 Nov 1. doi: 10.1097/DCR.0000000000001188.
    PubMed     Text format     Abstract available
    
    
19. ZERHOUNI YA, Trinh QD, Lipsitz S, Goldberg J, et al
    Effect of Medicaid Expansion on Colorectal Cancer Screening Rates.
    Dis Colon Rectum. 2018 Nov 7. doi: 10.1097/DCR.0000000000001260.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

20. LORIMIER G, Seegers V, Coudert M, Dupoiron D, et al
    Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study.
    Eur J Surg Oncol. 2018;44:1824-1831.
    PubMed     Text format     Abstract available
    
    
21. MONTRONI I, Ugolini G, Saur NM, Spinelli A, et al
    Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Comm
    Eur J Surg Oncol. 2018;44:1685-1702.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

22. KRUGLIAK CLEVELAND N, Huo D, Sadiq F, Sofia MA, et al
    Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
    Gastrointest Endosc. 2018;87:1304-1309.
    PubMed     Text format     Abstract available
    
    
23. NAGATA M
    Usefulness of underwater endoscopic submucosal dissection in saline solution with a monopolar knife for colorectal tumors (with videos).
    Gastrointest Endosc. 2018;87:1345-1353.
    PubMed     Text format     Abstract available
    
    
24. VLEUGELS JLA, Sahin H, Hazewinkel Y, Koens L, et al
    Endoscopic detection rate of sessile serrated lesions in Lynch syndrome patients is comparable with an age- and gender-matched control population: case-control study with expert pathology review.
    Gastrointest Endosc. 2018;87:1289-1296.
    PubMed     Text format     Abstract available
    
    
25. NISHIKAWA J, Miura O, Hashimoto S, Sakaida I, et al
    Colon adenoma with 2 too-long stalks (with video).
    Gastrointest Endosc. 2018;87:1590-1592.
    PubMed     Text format    
    
    
26. TATE DJ, Desomer L, Awadie H, Goodrick K, et al
    EMR of laterally spreading lesions around or involving the appendiceal orifice: technique, risk factors for failure, and outcomes of a tertiary referral cohort (with video).
    Gastrointest Endosc. 2018;87:1279-1288.
    PubMed     Text format     Abstract available
    
    
27. SAKAMOTO T, Nakajima T, Matsuda T, Murakami Y, et al
    Comparison of the diagnostic performance between magnifying chromoendoscopy and magnifying narrow-band imaging for superficial colorectal neoplasms: an online survey.
    Gastrointest Endosc. 2018;87:1318-1323.
    PubMed     Text format     Abstract available
    
    
28. DAVEE T, Coronel E, Papafragkakis C, Thaiudom S, et al
    Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
    Gastrointest Endosc. 2018 Jan 5. pii: S0016-5107(18)30005.
    PubMed     Text format     Abstract available
    
    
29. CAMERON K, Moss A
    Is 35 the new 50? Challenges in determining colonoscopy surveillance recommendations for young patients with incidentally detected adenomas.
    Gastrointest Endosc. 2018;88:826-829.
    PubMed     Text format    
    
    
30. YANG HJ, Cho CW, Kim SS, Ahn KS, et al
    Application of deep learning to predict advanced neoplasia using big clinical data in colorectal cancer screening of asymptomatic adults.
    Gastrointest Endosc. 2018 Nov 4. pii: S0016-5107(18)33254.
    PubMed     Text format     Abstract available
    
    
31. TRINDADE AJ, Rishi A, Hirten R, Inamdar S, et al
    Identification of volumetric laser endomicroscopy features of colon polyps with histologic correlation.
    Gastrointest Endosc. 2018;87:1558-1564.
    PubMed     Text format     Abstract available
    
    
32. LEE YJ, Yoon JY, Park JJ, Park SJ, et al
    Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstruction.
    Gastrointest Endosc. 2018;87:1548-1557.
    PubMed     Text format     Abstract available
    
    
33. KIM HS, Jung HY, Park HJ, Kim HM, et al
    Hot snare polypectomy with or without saline solution/epinephrine lift for the complete resection of small colorectal polyps.
    Gastrointest Endosc. 2018;87:1539-1547.
    PubMed     Text format     Abstract available
    
    
34. HAMOUDAH T, Ma K, Esteban M, Hayat W, et al
    Patients with small and diminutive proximal hyperplastic polyps have higher rates of synchronous advanced neoplasia compared with patients without serrated lesions.
    Gastrointest Endosc. 2018;87:1518-1526.
    PubMed     Text format     Abstract available
    
    
35. MALMSTROM ML, Saftoiu A, Riis LB, Hassan H, et al
    Dynamic contrast-enhanced EUS for quantification of tumor perfusion in colonic cancer: a prospective cohort study.
    Gastrointest Endosc. 2018;87:1530-1538.
    PubMed     Text format     Abstract available
    
    

    
    Gut

36. BAHIN FF, Heitman SJ, Rasouli KN, Mahajan H, et al
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2018;67:1965-1973.
    PubMed     Text format     Abstract available
    
    
37. BUGAJSKI M, Wieszczy P, Hoff G, Rupinski M, et al
    Modifiable factors associated with patient-reported pain during and after screening colonoscopy.
    Gut. 2018;67:1958-1964.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

38. FU X, Huang Y, Fan X, Deng Y, et al
    Demographic Trends and KRAS/BRAF(V600E) Mutations in Colorectal Cancer Patients of South China: a Single-site Report.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31973.
    PubMed     Text format     Abstract available
    
    
39. AMITAY EL, Cuk K, Niedermaier T, Weigl K, et al
    Factors Associated with False Positive Fecal Immunochemical Tests in a Large German Colorectal Cancer Screening Study.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31972.
    PubMed     Text format     Abstract available
    
    
40. SUENAGA M, Cao S, Zhang W, Yang D, et al
    Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31968.
    PubMed     Text format     Abstract available
    
    
41. WANG G, Wang Q, Huang Q, Chen Y, et al
    Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31978.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

42. MILONE M, Manigrasso M, Elmore U, Maione F, et al
    Short- and long-term outcomes after transverse versus extended colectomy for transverse colon cancer. A systematic review and meta-analysis.
    Int J Colorectal Dis. 2018 Nov 6. pii: 10.1007/s00384-018-3186.
    PubMed     Text format     Abstract available
    
    
43. UEHARA H, Yamazaki T, Iwaya A, Hirai M, et al
    A rare case of peritoneal deposits with carbon pigmentation after preoperative endoscopic tattooing for sigmoid colon cancer.
    Int J Colorectal Dis. 2018 Nov 5. pii: 10.1007/s00384-018-3189.
    PubMed     Text format     Abstract available
    
    
44. JUROWICH C, Lichthardt S, Matthes N, Kastner C, et al
    Comparison of conventional access routes for right hemicolectomy in colon cancer-data from the DGAV StuDoQ registry.
    Int J Colorectal Dis. 2018 Nov 3. pii: 10.1007/s00384-018-3188.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

45. LIAO CK, Chiang JM, Tsai WS, You JF, et al
    Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis.
    J Surg Oncol. 2018 Nov 8. doi: 10.1002/jso.25270.
    PubMed     Text format     Abstract available
    
    
46. CHOUHAN H, Sammour T, Thomas ML, Moore JW, et al
    The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25275.
    PubMed     Text format     Abstract available
    
    
47. CHAKEDIS J, Beal EW, Sun S, Galo J, et al
    Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    J Surg Oncol. 2018;118:1065-1073.
    PubMed     Text format     Abstract available
    
    
48. SUAREZ J, Goicoetxea A, Gomez ML, Jimenez G, et al
    Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective study.
    J Surg Oncol. 2018;118:1122-1128.
    PubMed     Text format     Abstract available
    
    
49. REYNOLDS IS, McNamara DA, Kay EW, O'Neill B, et al
    The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    J Surg Oncol. 2018;118:1129-1134.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

50. MURPHY JE, Shampain K, Riley LE, Clark JW, et al
    Case 32-2018: A 36-Year-Old Pregnant Woman with Newly Diagnosed Adenocarcinoma.
    N Engl J Med. 2018;379:1562-1570.
    PubMed     Text format    
    
    

    
    Oncogene

51. HU YB, Yan C, Mu L, Mi YL, et al
    Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Oncogene. 2018 Nov 2. pii: 10.1038/s41388-018-0557.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

52. LIN WC, Wang WH, Lin YH, Leu JD, et al
    Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinomabearing mouse model.
    Oncol Rep. 2018;40:1390-1400.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

53. TOIYAMA Y, Oki S, Okugawa Y, Ide S, et al
    Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Oncology. 2018;95:270-280.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

54. SHAH MS, DeSantis T, Yamal JM, Weir T, et al
    Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
    PLoS One. 2018;13:e0207002.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: